Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
- 28 February 2005
- journal article
- other
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42 (2), 275-276
- https://doi.org/10.1016/j.jhep.2004.10.028
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3*1, *2Journal of Hepatology, 2004
- Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?Journal of Hepatology, 2004
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002Hepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999